Cite

    Fu, J. et al. (2021). Increased risk of major congenital malformations in early pregnancy use of angiotensin‐converting‐enzyme inhibitors and angiotensin‐receptor‐blockers: a meta‐analysis. Diabetes/metabolism research and reviews. 37 (8), p. n/a. [Online].